Bob Bushok (@bobbushok) header
Bob Bushok (@bobbushok) profile picture
Cleveland, OH USA
Joined October 2023
Photo by Bob Bushok (@bobbushok)Photo by Bob Bushok (@bobbushok)
Bob Bushok retweeted
Thanks to everyone who stopped by the Vesalio booth at #TCT2026. It was exciting to see the international and U.S. communities come together to put evidence and experience to work. We enjoyed sharing #enVast and the NATURE RCT findings on large thrombus burden. #DoTheDropZone
2
5
116
Bob Bushok retweeted
Is it time to rethink your first move in primary PCI? Visit us at #TCT2026 & learn about the NATURE RCT showing a 26% smaller infarct size in the #enVast arm, compared to conventional PCI in #STEMI patients presenting w/ LTB. #DoTheDropZone Ref jacc.org/doi/10.1016/j.jacc.…
3
3
145
Bob Bushok retweeted
How are you treating patients w/ large thrombus burden (LTB)? Visit us at TCT & learn about the NATURE randomized controlled trial showing a 26% smaller infarct size in the #enVast arm than in conventional PCI in #STEMI patients presenting w/ #LTB. Ref doi.org/10.1016/j.jacc.2026.…
2
3
159
Bob Bushok retweeted
We welcome Daniel Davis! He’s joining Vesalio’s Board of Directors and serving as Advisor to our CEO, Steve Rybka. 25+ years building thrombectomy businesses at Penumbra and Imperative Care. Read the full release: vesalio.com/vesalio-appoints… #LeaveNoClotBehind
3
4
135
Bob Bushok retweeted
Coverage from @WebullGlobal on the #NATUREStudy following its presentation at #ESC2026. ➡️webull.com/news/154861817758… enVast is FDA-cleared & CE-marked. See vesalio.com/envast-ifu-fda or vesalio.com/envast-ifu-ce depending on your region, for indications, safety & warnings.
2
2
66
Bob Bushok retweeted
Professor Marco Valgimigli discusses the NATURE study following presentation of the results at #ESC2026 in this interview with Dr. Mirvat Alasnag, Dr. @SimoneBiscaglia and Dr. Jasper Boeddinghaus. #NATUREStudy @vlgmrc @mirvatalasnag Link to discussion: youtube.com/watch?v=2zAIJ5Sv…
1
5
6
783
Bob Bushok retweeted
This JACC editorial by Ziad A. Ali, MD discusses the NATURE study post-#ESC2026. #NATUREStudy @ziadalinyc jacc.org/doi/10.1016/j.jacc.…
1
2
5
543
Bob Bushok retweeted
Dr @vlgmrc and Dr @CMichaelGibson discuss the NATURE study and the results presented at #ESC2026. #NATUREStudy enVast is FDA-cleared & CE-marked. See vesalio.com/envast-ifu-fda or vesalio.com/envast-ifu-ce depending on your region, for indications, safety information & warnings.
Dr. Marco Valgimigli and Dr. C. Michael Gibson discuss the NATURE trial: enVast thrombectomy as an adjunctive reperfusion strategy reduced the infarct size by 25% compared to conventional PCI in STEMI patients with large thrombus burden. Watch video here: clinicaltrialresults.org/wp-…
1
1
232
Dr. Marco Valgimigli and Dr. C. Michael Gibson discuss the NATURE trial: enVast thrombectomy as an adjunctive reperfusion strategy reduced the infarct size by 25% compared to conventional PCI in STEMI patients with large thrombus burden. Watch video here: clinicaltrialresults.org/wp-…
8
1
24
3,604
Bob Bushok retweeted
Great week at #iCureStroke2026/Istanbul! Drs Ribó, @ArsidaBajrami & Jesser shared strong #NeVa/#NeVaNET cases to a packed room. Thanks Prof Geyik, @RaulNogueiraMD, @DekonGroup & faculty for a rich, case-based symposium. Partner with us. #DoTheDropZone #LeaveNoClotBehind @DTangun
2
3
146
Bob Bushok retweeted
The Vesalio team is at #SNIS2026 sharing latest updates on #NeVaVS - the only FDA-approved device for the treatment of cerebral #vasospasm due to #aSAH. 🧠 🗓️ Please visit us at Booth #404 or 📲 DM @bobbushok to connect! Hope to see you soon! @SNISinfo
2
5
181
Bob Bushok retweeted
Congrats to Dr Paparoni, Dr Lezzi, Dr Remigis & ASL Teramo's Emodinamica team on this #enVast case. enVast is FDA-cleared and CE-marked. See vesalio.com/envast-ifu-fda or vesalio.com/envast-ifu-ce depending on your region, for indications, safety & warnings. ➡️linkedin.com/posts/hernan-ve…
2
4
189
Bob Bushok retweeted
How do you reduce overnight thrombolysis or open surgery when a hard, distal clot is below the knee or in the arm? Learn how #pVasc uses a streamlined approach and the lowest profile delivery to remove clot at #ISET2025. Hope to see you there! #DoTheDropZone @ISETNews
1
3
145
Bob Bushok retweeted
💥Got a tough distal clot below the knee or in the arm? Discover a cutting-edge approach to removing clots efficiently with our low-profile #pVasc device! Learn all about our innovative solutions at #VEITH24. More Info, DM @bobbushok @VEITHsymposium #PeripheralArterialDisease
3
9
459